GLP-1 receptor agonists, carotid atherosclerosis and retinopathy

Expert Opin Pharmacother. 2017 Aug;18(12):1163-1165. doi: 10.1080/14656566.2017.1342810. Epub 2017 Jun 21.

¹ a Biomedical Department of Internal Medicine and Medical Specialties , University of Palermo , Palermo , Italy.
² b Department of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section , University of Palermo , Palermo , Italy.
³ c Diabetes Centre, Second Department of Internal Medicine , Democritus University of Thrace , Alexandroupolis , Greece.
⁴ d Department of Internal Medicine , Fondazione IRCCS Ca' Granda-Ospedale Maggiore , Milan , Italy.
⁵ e Department of Clinical Sciences and Health Community , University of Milan , Milan , Italy.

No abstract available

Keywords: Cardiovascular risk; carotid atherosclerosis; glucagon-like peptide 1 receptor agonists; retinopathy.